Phreesia (NYSE:PHR) Sets New 52-Week Low on Insider Selling

Phreesia, Inc. (NYSE:PHR) shares hit a new 52-week low during trading on Wednesday after an insider sold shares in the company. The stock traded as low as $15.40 and last traded at $15.6190, with a volume of 349032 shares traded. The stock had previously closed at $15.73.

Specifically, CFO Balaji Gandhi sold 4,687 shares of the firm’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total transaction of $76,679.32. Following the sale, the chief financial officer owned 150,569 shares of the company’s stock, valued at approximately $2,463,308.84. This trade represents a 3.02% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 3,995 shares of Phreesia stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total transaction of $65,358.20. Following the transaction, the general counsel directly owned 169,661 shares of the company’s stock, valued at approximately $2,775,653.96. This trade represents a 2.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In other news, insider David Linetsky sold 6,038 shares of the stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $98,781.68. Following the completion of the transaction, the insider owned 223,942 shares of the company’s stock, valued at approximately $3,663,691.12. This represents a 2.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. KeyCorp cut their price target on Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a report on Wednesday, October 8th. DA Davidson lifted their price target on shares of Phreesia from $33.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 2nd. Robert W. Baird reduced their target price on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, December 10th. Canaccord Genuity Group reduced their target price on Phreesia from $38.00 to $33.00 and set a “buy” rating for the company in a report on Tuesday, December 9th. Finally, Mizuho cut their target price on Phreesia from $36.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, December 10th. Seventeen analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $30.06.

Phreesia News Roundup

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Recent quarterly results show revenue growth and an EPS beat vs. expectations (revenue up ~12.7% year‑over‑year; EPS beat in the prior reported quarter), which supports the company’s growth story and underpins analyst buy ratings. MarketBeat PHR Profile
• Positive Sentiment: Street coverage remains largely constructive: the consensus is a “Moderate Buy” with a midpoint price target (~$30) well above the current trading level — this provides upside potential if execution continues. Analyst Coverage
• Neutral Sentiment: Although insiders sold shares, the officers still hold material stakes (examples from filings: Evan Roberts ~826k shares; David Linetsky ~224k; Allison Hoffman ~170k; Balaji Gandhi ~150k; Amy Beth Vanduyn ~159k), which moderates concerns about complete loss of insider conviction. Sample SEC Form 4
• Negative Sentiment: Coordinated insider selling on Jan. 15–16 by multiple senior executives (CFO Balaji Gandhi, GC Allison Hoffman, EVP Evan Roberts, David Linetsky and SVP Amy Beth Vanduyn) totaled tens of thousands of shares sold at roughly $16.36–$16.38 per share. The size and timing of those sales have likely contributed to the stock’s weakness today by signaling near‑term selling pressure. InsiderTrades Summary

Phreesia Price Performance

The stock has a market capitalization of $939.87 million, a price-to-earnings ratio of -155.98 and a beta of 0.61. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The stock has a 50 day moving average price of $18.10 and a 200-day moving average price of $23.09.

Phreesia (NYSE:PHR) last released its earnings results on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.11. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The company had revenue of $120.33 million during the quarter, compared to the consensus estimate of $119.98 million. During the same period in the previous year, the company posted ($0.25) EPS. Phreesia’s revenue was up 12.7% compared to the same quarter last year. On average, analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently bought and sold shares of the business. Federated Hermes Inc. acquired a new stake in shares of Phreesia during the 3rd quarter valued at about $32,000. Asset Management One Co. Ltd. acquired a new stake in shares of Phreesia in the third quarter valued at approximately $45,000. State of Alaska Department of Revenue acquired a new position in Phreesia during the third quarter worth approximately $83,000. Farther Finance Advisors LLC increased its holdings in shares of Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new stake in shares of Phreesia during the third quarter worth approximately $118,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.